77 unknown. 77 Phase 2, 21 Phase 1, 21 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 77 | Unknown 77 |
| Phase 1 | 21 | Unknown 21 |
| Phase 3 | 21 | Unknown 21 |
Follow Heart Failure: new trials by email Literature Review of Heart Failure trials Research Report on Heart Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale Dapagliflozin tablet, Empagliflozin Tablets - Heart Failure | Phase 2 | Unknown | Centre Hospitalier Universitaire Vaudois | 12 | 2024-08-01 | 2024-02-07 |
| Mechanisms of Semaglutide Therapy in Heart Failure Patients Semaglutide - Heart Failure, Obesity | Phase 1 / Phase 2 | Unknown | University Medical Centre Ljubljana | 10 | 2024-07-10 | 2024-08-07 |
| Cardiovascular Genistein Therapy for Heart Failure Inflammation Genistein - Heart Failure | Phase 1 / Phase 2 | Unknown | University Medical Centre Ljubljana | 40 | 2024-07-01 | 2024-07-15 |
| REMAP ECMO - Beta Receptor Modulation Trial Esmolol - Heart Failure, Cardiogenic Shock | Phase 2 | Unknown | Erasmus Medical Center | 20 | 2024-06-01 | 2024-07-26 |
| Effect of the PLAN CUIDARTE on the Caregiving Competence of People With Heart Failure PLAN CUIDARTE, Conventional care - Heart Failure, Caregiver Burden | Phase 2 | Unknown | Universidad de la Sabana | 84 | 2024-03-25 | 2024-03-13 |
| Management of Volume Overload HF Patients by Individual DSR Treatment adJustment-a clinicAl inVestigation of InfusatE2.0 Direct Sodium Removal Infusate 2.0 - Heart Failure, Volume Overload | Phase 1 / Phase 2 | Unknown | Sequana Medical N.V. | 33 | 2023-07-07 | 2023-07-28 |
| A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients Control group:DH001 placebo, Trial group: DH001 low-dose group, Trial group: DH001 high-dose group - Cancer, Heart Failure | Phase 2 | Unknown | Monyan Pharmaceutical (Shanghai) Co., Ltd. | 90 | 2023-04-04 | 2023-10-23 |
| " Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD " Sacubitril 49 MG / Valsartan 51 MG [Entresto] BID, Empagliflozin 10 MG OD - Congenital Heart Disease, Heart Failure | Phase 2 / Phase 3 | Unknown | Instituto Nacional de Cardiologia Ignacio Chavez | 160 | 2023-02-06 | 2022-11-02 |
| A Pilot Study: Preventing Adverse Remodelling Following Pacemaker Implantation Optimised programming, Lisinopril, Standard care - Pacemakers, Heart Failure | Phase 2 | Unknown | University of Leeds | 75 | 2022-12-01 | 2022-11-02 |
| Treating Heart Failure With hiPSC-CMs hiPSC-CM therapy, Control - Heart Failure | Phase 1 / Phase 2 | Unknown | HELP Therapeutics Co., Ltd. | 20 | 2022-06-30 | 2023-11-22 |
| Cardiometabolic Effects of Dapagliflozin in Heart Failure With Reduced or Mildly Reduced Ejection Fraction Dapagliflozin - Heart Failure, Reduced Ejection Fraction | Phase 2 | Unknown | Assistance Publique - Hôpitaux de Paris | 40 | 2022-06-26 | 2022-12-09 |
| Biomarker Study: Heart Failure Patients at Risk Angiotensin 1-7, Saline solution - Heart Failure NYHA Class II, Heart Failure NYHA Class III | Phase 1 / Phase 2 | Unknown | University of Arizona | 40 | 2022-04-01 | 2022-04-20 |
| Levosimendan in Patients With Impaired Right Ventricular Function Undergoing Cardiac Surgery Levosimendan, Standard Care - Right Heart Failure, Open-heart Surgery | Phase 2 | Unknown | Ain Shams University | 40 | 2021-08-18 | 2021-10-20 |
| Acupuncture for the Treatment of Medication-Dependent Hypotension in Heart Failure True Acupuncture, Sham Acupuncture - Congestive Heart Failure, Hypotension | Phase 1 / Phase 2 | Unknown | Scripps Health | 40 | 2021-04-20 | 2021-07-07 |
| Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial Apixaban, Placebo - Heart Failure, Sinus Rhythm | Phase 2 | Unknown | Korea University Guro Hospital | 200 | 2021-03-02 | 2021-01-20 |
| Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction Wenyang Huoxue Decoction, Wenyang Huoxue placebo - Heart Failure, Myocardial Infarction | Phase 2 | Unknown | Jun Li | 200 | 2021-01-15 | 2021-01-06 |
| Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction Modified Wenxin Decoction - Heart Failure, Myocardial Infarction | Phase 2 | Unknown | Jun Li | 200 | 2020-12-15 | 2020-12-14 |
| Role of Perhexiline in Hypertrophic Cardiomyopathy Perhexiline, Placebo - Hypertrophic Cardiomyopathy | Phase 2 | Unknown | Flinders University | 60 | 2020-12-01 | 2021-03-11 |
| ICMNC-HF. IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients Intracoronary injection of stem cell, Placebo - Heart Failure | Phase 1 / Phase 2 | Unknown | SCARM Institute, Tabriz, Iran | 5 | 2020-10-20 | 2020-03-17 |
| IMMNC-HF: IntraMyocardial Injection of Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients Intramyocardial injection of stem cell, Placebo - Heart Failure | Phase 1 / Phase 2 | Unknown | SCARM Institute, Tabriz, Iran | 5 | 2020-10-14 | 2020-10-27 |
Showing 20 of 77. Sign in to see all of them.
Myocardial Infarction (6) · Cardiomyopathy, Dilated (3) · Cardiovascular Diseases (3) · Coronary Artery Disease (3) · Heart Defects, Congenital (3) · Angina Pectoris (2) · Arrhythmias, Cardiac (2) · Cardiomyopathies (2) · Cardiotoxicity (2) · Diabetes Mellitus (2) · Heart Diseases (2) · Heart Failure, Systolic (2) · Hypertension (2) · Ketosis (2)
Heart Diseases (75) · Cardiovascular Diseases (74) · Pathological Conditions, Signs and Symptoms (25) · Pathologic Processes (19) · Vascular Diseases (18) · Myocardial Ischemia (11) · Infarction (8) · Ischemia (8) · Necrosis (8) · Nutritional and Metabolic Diseases (6) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Respiratory Tract Diseases (5) · Signs and Symptoms (5) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4)
dapagliflozin (4) · BID protein, human (2) · Control Groups (2) · Ivabradine (2) · Simendan (2) · Standard of Care (2) · empagliflozin (2) · Acetylcysteine (1) · Atorvastatin (1) · Bisoprolol (1) · Bosentan (1) · Carbon Dioxide (1) · Cholecalciferol (1) · Coronary Artery Bypass (1) · Dobutamine (1)
Ethicare GmbH (3) · Bioheart, Inc. (2) · Guy's and St Thomas' NHS Foundation Trust (2) · Jun Li (2) · SCARM Institute, Tabriz, Iran (2) · University Medical Centre Ljubljana (2) · University of Aarhus (2) · University of Leeds (2) · Acorn Cardiovascular, Inc. (1) · Affiliated Hospital to Academy of Military Medical Sciences (1) · Ain Shams University (1) · Assistance Publique - Hôpitaux de Paris (1) · Azienda Unita' Sanitaria Locale Di Modena (1) · Bambino Gesù Hospital and Research Institute (1) · Bayside Health (1)
United States (9) · China (8) · United Kingdom (8) · Netherlands (6) · Canada (5) · Italy (5) · Australia (4) · Brazil (4) · Iran (4) · Austria (3) · Denmark (3) · Germany (3) · Hungary (3) · Israel (3) · Serbia (3)
Ida Jovanovic, Prof,MD,PhD (3) · Michael Burch, Prof,MD,PhD (3) · Christoph Male, Prof,MD,PhD (2) · Elgar Anamzadeh, MD, Cardiologist (2) · Jun Li, MD (2) · Michiel Dalinghaus, MD,PhD (2) · Mohammad Nouri, Ph.D (2) · Peyman Keyhanvar, MD, Ph.D (2) · Raheleh Farahzadi, Ph.D (2) · Yousef Faridvand, Ph.D (2) · Ahmad Amin, MD (1) · Andreas M Zeiher, MD (1)
PMID 17090774, PMID 19118718, PMID 21709062, PMID 29386200, PMID 9462531, PMID 12947373, PMID 15475828, PMID 16181823, PMID 17086092, PMID 17566702, PMID 18297097, PMID 20008582, PMID 20090057, PMID 20154234, PMID 21712261, PMID 21784540, PMID 21794114, PMID 22286156, PMID 22300693, PMID 22308084, PMID 22677455, PMID 22893340, PMID 23219310, PMID 23616602, PMID 23680589, PMID 24614322, PMID 24656645, PMID 25142068, PMID 25520374, PMID 26727047, PMID 27469019, PMID 28416392, PMID 28880460, PMID 29017565, PMID 29236912, PMID 30520545, PMID 32368692, PMID 32865377, PMID 33186500, PMID 33447845, PMID 33832352, PMID 34534493, PMID 34826125, PMID 36618925, PMID 37120736, PMID 38273436, PMID 38331891, PMID 38572643
2015 (4), 2019 (2), 2023 (1)